• Research & Development

Since 2011, we have seen apparent success in 4 skin cancer patients who have self-administered CS-S/BCC-1 –cannabinoid based extracts topically to their basal and squamous cell carcinomas. These patients have experienced shrinking and apparent eradication of their skin cancer lesions, backed by positive reports from their doctors. With these results, Cannabis Science is confident it can begin programs for over the counter (OTC) and prescription drug markets.  The company is consulting with a team of FDA specialists to plan for a pre-IND meeting with the agency with the goal of creating a road map leading to an IND application.

Connect With Us


Facebook  Twitter  This email address is being protected from spambots. You need JavaScript enabled to view it. Go to USTREAM

People Behind the Scenes

Dr. Robert Melamede, Ph.D.
"The endocannabinoid system provides unique opportunities for regulating homeostasis to promote health with phyto-cannabinoid based pharmaceuticals."
Meet Dr. Robert Melamede, Ph.D. >